3-Bromo-4-chloro-6-(trifluoromethyl)quinoline, 95+%, 1g

Methyl 2-(((benzyloxy)carbonyl)amino)-2-(oxetan-3-ylidene)acetate, 95.0%, 1g

6-Chloro-n-(prop-2-yn-1-yl)pyridine-3-carboxamide, 95%, 5g

2-Methyl-1-(pyridin-2-yl)propan-2-aminedihydrochloride, 1g

4-Nitro-1,3-dihydro-2H-benzimidazol-2-one, 97.0%, 25g

1-[3-(4-Fluoro-benzyl)-[1,2,4]thiadiazol-5-yl]-piperazine, 95.0%, 1g

1-(2-Bromothiazol-4-yl)ethan-1-one, 98%, 250mg

(3-(Hydroxymethyl)-4-methoxyphenyl)boronic acid, 95.0%, 25g

5-Methoxy-7-azaindole, 98.0%, 250mg

2-(N,N-Dimethylamino)benzaldehyde, 95.0%, 1g

Scintillation vials 20 ml Caps made from PP with PE foam seal, borosilicate glass, 500 Piece(s)

1-(Difluoromethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one, 98%, 250mg

TAZEMETOSTAT, 98%, 5g